Subscribe to our Email Alerts

Amplia appoints new CFO

Amplia Therapeutics has today announced that Mr Tim Luscombe will replace Mr Hamish George as Chief Financial Officer (CFO) of the Company. 
Mr Luscombe is a highly experienced Chartered Accountant who holds a Bachelor of Commerce from the University of Melbourne and a Certificate in Governance Practice from the Governance Institute of Australia. He is a Director at Bio101 Financial Advisory and has been working with Amplia in a senior accounting capacity over the last two years. 
Amplia’s CEO and Managing Director, Dr Chris Burns, commented:  
“We are delighted that Tim is taking on the role of CFO at Amplia. His knowledge of the company and close working relationship with the team means it will be a seamless transition. We would also like to thank Hamish for his excellent work over the previous years.” 
Click here to read the ASX release.